Solasta Ventures
Venture capitalBoston · Seed–Series C · 6 people tracked
Also known as SOLASTA VENTURES, INC.
Investment thesis
Solasta Ventures focuses on healthcare and life sciences, investing in companies working to advance medicine. The team brings more than 30 years of combined experience across healthcare investments and drug development, and invites founders whose mission aligns with advancing medicine to connect.
Source: firm website, verified Aug 25, 2026.
Team · 6 people
from the firm's website
What they invest in
from 28 of 32 portfolio companiesBiotech ×25Healthtech ×15Medical Devices ×6Deep Tech ×5AI & Machine Learning ×2Consumer ×2B2B Marketplaces ×1Digital Health ×1
HQs:United States×20United Kingdom×1
Who they back
founder profiles across 11 portfolio companiesFounding team size:solo founder×72 founders×33 founders×1
Investments · 32 tracked
founders shown can be your intro pathBy year:2024 · 12023 · 42021 · 22020 · 12015 · 19 dated
Arvinas is a biopharmaceutical company developing PROTAC protein degrader therapies, with a pipeline focused on oncology and neurology.
BiotechHealthtechNew Haven, US
Sean Cassidy(Executive Officer)Manuel Litchman(Executive Officer, Director)
BoardStephen Squinto(Director)inLiam Ratcliffe(Director)inTim Shannon(Director)inKush Parmar(Director)
Co-investors5AM VenturesAccess BiotechnologyCanaan PartnersConnecticut InnovationsNextech InvestRA Capital+1 more
Kymera is a clinical-stage biotechnology company developing novel medicines using targeted protein degradation technology to treat diseases caused by previously "undrugged" proteins.
BiotechDeep TechHealthtech
Nello Mainolfi(Founder)in
Co-investorsAtlas VentureAvoro Capital AdvisorsBain Capital Life SciencesBessemer Venture PartnersHatteras Venture PartnersMRL Ventures Fund+3 more
Rallybio is a clinical-stage biotech company developing therapies for people with severe and rare diseases, with a pipeline focused on complement dysregulation and hematology.
BiotechHealthtechNew Haven, US
Steve Uden(Co-Founder & Chief Executive Officer)Stephen Uden(Founder)inMartin(Co-Founder & Chairman)Jon(Chief Financial Officer)
Co-investors5AM VenturesCanaan PartnersConnecticut InnovationsF-Prime CapitalMitsui Global Investment
Seer develops proteomics tools for large-scale protein analysis, including an assay, automation instrument, and analysis software for studying the proteome across human and non-human samples.
BiotechDeep TechHardwareHealthtech
Omid Farokhzad(Chair and Chief Executive Officer)in
Co-investorsSoftBank Vision FundWingaMoonMaverick Ventures
Synlogic develops synthetic biology-based biotherapeutics that use engineered living organisms to treat diseases.
BiotechDeep TechMedical DevicesCambridge, US
Bharatt Chowrira(Executive Officer)Michael Sheahan(Executive Officer)Jose Carlos Gutierrez-Ramos(Executive Officer, Director)Paul Miller(Executive Officer)Aoife Brennan(Executive Officer)Todd Shegog(Executive Officer)
Co-investorsAtlas VentureNew Enterprise Associates (NEA)NSG VenturesPfizer Venture InvestmentsSofinnova VenturesOrbiMed
Xilio Therapeutics is a clinical-stage biotechnology company developing masked immuno-oncology therapies that use protein engineering to remain inactive until activated by tumor-specific proteases within the tumor microenvironment.
BiotechHealthtechWaltham, US
Rene Russo(Executive Officer, Director)inJoseph Farmer(Executive Officer)Timothy Clackson(Executive Officer)Paul Clancy(Director)Daniel Curran(Director)Nancy Hong(Director)
Co-investorsBain Capital Life SciencesBay City CapitalF-Prime CapitalM VenturesMRL Ventures FundRA Capital+4 more
Trefoil Therapeutics is a clinical-stage biotechnology company developing therapeutic agents for corneal diseases.
BiotechHealthtechMedical DevicesSan Diego, US
David Eveleth(Executive Officer, Director)Schalon Newton(Executive Officer)
BoardChristy Shaffer(Director)inRalph Bradshaw(Director)
Co-investorsExSight VenturesAccess BiotechnologyBios PartnersCorrelation VenturesFemHealth VenturesHatteras Venture Partners+2 more
Co-investors+ND CapitalSanofi Ventures
Co-investorsAvoro Capital AdvisorsEpidarex CapitalF-Prime CapitalKeyhorse CapitalSofinnova VenturesvenBio Partners
Arcellx develops CAR T-cell therapies that are individually designed for each patient, using the immune system to target and attack cancer.
BiotechHealthtechGaithersburg, US
Han Lee(Executive Officer)Rami Elghandour(Executive Officer, Director)
BoardJill Carroll(Director)inAli Behbahani(Director)inDerek Yoon(Director)inTiba Aynechi(Director)in
Co-investorsLG Technology VenturesNew Enterprise Associates (NEA)Quan CapitalSamsara BioCapitalSixty Degree CapitalSR One Capital Management+2 more
Axonis Therapeutics is a biotechnology company developing small-molecule medicines that target KCC2, a mediator of inhibition in the brain, to treat neurological disorders such as epilepsy and pain.
BiotechDeep TechBoston, US
Shane Hegarty(Executive Officer)Shane V. Hegarty(Chief Scientific Officer & Co-Founder)Jeffrey Imbaro(Executive Officer)Joanna Stanicka(Chief Executive Officer, President & Co-Founder)inJeff Imbaro(Chief Operating Officer)Tiasha Shafiq(Chief of Staff)
Co-investorsvenBio PartnersMRL Ventures FundSofinnova VenturesCivilization Ventures Management, LlcCreative Destruction Lab (CDL)Hatteras Venture Partners+7 more
Co-investorsAvoro Capital AdvisorsRapha Capital Management, LLC
Boxhub operates an online marketplace for buying and selling shipping containers, modernizing the traditionally fragmented container trade through digital technology.
B2B MarketplacesE-commerceLogistics & Supply Chain
Maxmillian Birner(Co-Founder & CEO)Maximilian Birner(Founder)in
Co-investorsAlleyCorpAlley Robotics VenturesFJ LabsHum CapitalInterplay Ventures Early Stage Management Llc
The page presents Pinco Casino, an online gambling platform offering slots, live casino, table games, and sports betting with a Turkish-language interface.
ConsumerGamingBoston, US
Co-investorsAstellas Venture Management LLCDC Investment PartnersUTokyo Innovation Platform Co. Ltd.Agent CapitalLongwood Fund
CAR-Macrophage cellular therapeutics with initial oncology focus (NASDAQ: CARM).
BiotechPhiladelphia, US
Steven Kelly(Executive Officer, Director)
BoardMargarita Chavez(Director)Eran Nadav(Director)Althea Stillman(Director)Jacob Gunterberg(Director)Regina Hodits(Director)
Co-investorsAju IB Invesment CorporationAnzu PartnersGrazia Equity GmbHHealthCapMRL Ventures FundAgent Capital+1 more
BiotechBerkeley, US
Genine A. Winslow(Executive Officer, Director)Genine Winslow(Founder)inRan Geng(Director)Winnie Wan(Director)
Co-investorsBerkeley SkyDeck FundFuture Planet CapitalTachyon Ventures
Clearside Biomedical is an intellectual property holding, investment, and commercialization company focused on its suprachoroidal space (SCS) ocular drug-delivery platform and microinjector technology.
BiotechHealthtechMedical DevicesAlpharetta, US
Mark Prausnitz(Director)Charles Deignan(Executive Officer)Glenn Noronha(Executive Officer)Daniel H. White(Executive Officer, Director)
BoardEvgeny Zaytsev(Director)Derek Yoon(Director)in
Co-investorsHEALTHCARE ROYALTY PARTNERSMountain Group CapitalHatterasHatteras Venture Partners
Ensoma is a genomic medicine company developing a platform for in vivo engineering of hematopoietic stem cells (HSCs), combining an off-the-shelf delivery system with a gene engineering toolkit intended to treat diseases with a one-time treatment.
BiotechHealthtechMedical DevicesBoston, US
Co-investors5AM VenturesAju IB Invesment CorporationCatalio Capital Management, LPDelos CapitalF-Prime CapitalAlexandria+7 more
BiotechBranford, US
Donmienne Leung(Manager)Ian Taylor(Manager)Stephen Bloch(CEO and Manaager)
BoardDerek Yoon(Manager)Jasmina Marjanovic(Manager)inDenis Patrick(Manager)
Co-investorsPfizer Venture InvestmentsTakeda Ventures
G1 Therapeutics develops cancer therapies focused on improving patient outcomes and quality of life for people with cancer.
BiotechResearch Triangle Park, US
Mark A. Velleca(Executive Officer, Director)inTimothy Sullivan(Director)Gregory Mossinghoff(Executive Officer)Seth Rudnick(Director)Ron Laufer(Director)Michael Gutch(Director)
Co-investorsLumira VenturesMountain Group CapitalRA CapitalHatteras Venture Partners
HotSpot Therapeutics is a drug discovery company developing small-molecule allosteric medicines by targeting "natural hotspots" — regulatory on/off switches on proteins.
AI & Machine LearningBiotechHealthtech
Co-investorsAtlas VentureB Capital GroupB4 CapitalMRL Ventures FundSofinnova PartnersSR One Capital Management
Immunitas discovers and develops therapeutic antibodies for cancer and autoimmune diseases, with its lead program targeting CD161 for solid tumors and hematological malignancies.
BiotechDigital HealthMedical DevicesWaltham, US
Amanda Wagner(Executive Officer)Dan Matloff(Executive Officer)Jiaping Gu(Director)Jeffrey Goldberg(Executive Officer, Director)
BoardLaura Brass(Director)inKai Wucherpfennig(Director)
Co-investorsDC Investment PartnersLongwood FundMedical Excellence CapitalNovartis Venture FundOno Venture Investment, Inc.Agent Capital+2 more
BiotechSouth San Francisco, US
John F. Fowler(Executive Officer, Director)Christopher J. Kirk(Executive Officer, Director)
BoardDr. Gerald Chan(Director)Dr. Jean-Pierre Sommadossi(Director)
Co-investorsBay City CapitalChiesi VenturesPappas Capital
Maxion Therapeutics develops protein and antibody therapeutics using its patented KnotBody technology, which fuses cysteine-rich miniproteins (Knottins) into antibody binding loops to target ion channels and GPCRs.
BiotechHealthtechCambridge, GB
John McCafferty(Co-founder and CTO)inAneesh Karatt-Vellatt(Co-founder and CSO)in
Co-investorsLifeArc VenturesMonograph Capital PartnersGeneral Catalyst
Molecular Templates, Inc. was a clinical-stage biopharmaceutical company formerly based in Austin, TX.
BiotechAustin, US
Co-investorsLongitude CapitalSofinnova Ventures
Orionis Biosciences discovers and engineers molecules that connect proteins on or within cells to reprogram disease-driving processes or activate immune responses.
BiotechDeep TechNewton, US
Nikolai Kley(Founder)Nikolai Kley, Ph.D.(Executive Officer, Director)
BoardGriet Vanpoucke, Ph.D.(Director)Steven R. Gullans, Ph.D.(Director)
Co-investorsExcel Venture ManagementSolari CapitalV-Bio VenturesWessel Management
Prime Roots makes plant-based deli meats designed to match conventional meat in blind taste tests, using clean ingredients without nitrates or celery salt.
ConsumerFoodTech
Kimberlie Le(Founder)in
Co-investorsDiamond Edge VenturesDnx VenturesPangaea Ventures Us Inc.PortfoliaSpiral Sun VenturesAlumni Ventures+7 more
RAPT Therapeutics is a clinical-stage biopharmaceutical company developing therapeutics that target the immune system to treat inflammatory and immunologic diseases.
BiotechHealthtech
Co-investorsFrazier Life SciencesKleiner PerkinsThe Column GroupOrbiMed
ReCode develops mRNA and gene correction therapeutics for genetic diseases, using proprietary lipid nanoparticle technology to deliver treatments to specific organs.
AI & Machine LearningBiotechHealthtechMedical DevicesMenlo Park, US
Dr. Daniel J. SiegwartArthur E Johnson(Executive Officer, Director)
Co-investorsAju IB Invesment CorporationEcoR1 CapitalEvolution VC PartnersMPM BioImpactOrbiMedOUP (Osage University Partners)+6 more
Sutro develops a next-generation antibody-drug conjugate (ADC) platform for single- and dual-payload therapeutics aimed at treating cancer patients.
BiotechHealthtech
Co-investorsOwl Capital
EvolveImmune develops trispecific T cell engagers with integrated CD2 costimulation through its EVOLVE platform to address cancer cell resistance to immunotherapies.
BiotechHealthtech
Co-investorsPfizer Venture Investments
Exits · 6
IPOs and acquisitions across the tracked portfolioArvinas Holding Co. LLCNASDAQ: ARVNKymera TherapeuticsNASDAQ: KYMRRallybio, LLCNASDAQ: RLYBSeerNASDAQ: SEERSynlogicOTC: SYBXXilio TherapeuticsNASDAQ: XLO
Portfolio news
latest coverage across their companiesSeer · investing.com · Aug 20, 2026
Xilio Therapeutics · tickerreport.com · Aug 15, 2026
Arcellx · biobuzz.io · Aug 14, 2026
Ensoma · fiercebiotech.com · Aug 7, 2026
ReCode Therapeutics · geekwire.com · Jul 13, 2026
Clearside Biomedical · elevenflo.com · Mar 6, 2026
Trefoil Therapeutics · hatterasvp.com · Jan 9, 2026
Carisma Therapeutics · bizjournals.com · Dec 16, 2025
Frequently asked questions
- How many investments has Solasta Ventures made?
- Solasta Ventures has 29 tracked investments, including 1 dated in the last 24 months.
- What stage does Solasta Ventures invest at?
- Solasta Ventures invests at the Seed, Series A, Series B, Series C stages.
- What sectors does Solasta Ventures focus on?
- Solasta Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Solasta Ventures located?
- Solasta Ventures is headquartered in Boston, US.
- Who does Solasta Ventures co-invest with?
- Solasta Ventures most often shares deals with F-Prime Capital, MRL Ventures Fund, Pfizer Venture Investments, among 81 tracked co-investors.
Co-investors · 3
Madrona Venture Group is a Seattle-founded venture firm that partners with founders across early and acceleration stages, providing capital plus hands-on support in recruiting, strategy, business development, and fundraising.
Intel Capital is the corporate venture capital arm associated with Intel, investing in and supporting technology companies as they scale.
Propel Venture Partners is an early-stage venture capital firm that backs founders building companies for the new economy.
Firms observed investing alongside Solasta Ventures, from public investor directories. Shared companies are the overlap with Solasta Ventures's recorded portfolio.
Similar investors
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.